Table 4.
Wang et al. (top 10 % stable plasma miRNAs) | Wang et al. (top 10 % stable serum miRNAs) | Tonge et al. (top 10 % stable plasma miRNAs) |
---|---|---|
hsa-miR-106b | hsa-miR-106b | hsa-let-7a-5p |
hsa-miR-16 | hsa-miR-126 | hsa-let-7f-5p |
hsa-miR-185 | hsa-miR-140-3p | hsa-let-7i-5p |
hsa-miR-18a | hsa-miR-185 | hsa-miR-101-3p |
hsa-miR-19b | hsa-miR-191 | hsa-miR-103a-3p |
hsa-miR-222 | hsa-miR-1974 | hsa-miR-106b-3p |
hsa-miR-320a | hsa-miR-1979 | hsa-miR-10a-5p |
hsa-miR-320b | hsa-miR-19b | hsa-miR-10b-5p |
hsa-miR-324-3p | hsa-miR-320a | hsa - miR - 126 - 3p |
hsa-miR-345 | hsa-miR-320b | hsa - miR - 126 - 5 p |
hsa-miR-346 | hsa-miR-324-3p | hsa-miR-130a-3p |
hsa-miR-484 | hsa-miR-345 | hsa-miR-130b-3p |
hsa-miR-486-5p | hsa-miR-346 | hsa-miR-148b-3p |
hsa-miR-720 | hsa-miR-451 | hsa-miR-150-5p |
hsa-miR-92a | hsa-miR-720 | hsa-miR-151a-5p |
hsa-miR-92a | hsa-miR-16-5p | |
hsa-miR-934 | hsa-miR-181a-3p | |
hsa-miR-182-5p | ||
hsa - miR - 191 - 5p | ||
hsa-miR-21-5p | ||
hsa-miR-22-3p | ||
hsa-miR-221-3p | ||
hsa-miR-25-3p | ||
hsa-miR-26b-5p | ||
hsa-miR-28-3p | ||
hsa-miR-30a-3p | ||
hsa-miR-30a-5p | ||
hsa-miR-30d-5p | ||
hsa-miR-30e-5p | ||
hsa-miR-340-5p | ||
hsa-miR-342-3p | ||
hsa-miR-423-3p | ||
hsa-miR-423-5p | ||
hsa - miR - 451a | ||
hsa-miR-484 | ||
hsa-miR-486-5p | ||
hsa-miR-532-5p | ||
hsa-miR-92a-3p | ||
hsa-miR-92b-3p | ||
hsa-miR-99b-5p |
Italicised miRNAs—identified as stable in plasma in both studies. Italicised and underlined miRNAs—identified as being stable in plasma herein, and in serum by Wang et al